Jill Lacy

Jill Lacy is a Professor of Medicine in the Department of Internal Medicine at Yale School of Medicine, specializing in Gastrointestinal Malignancies with clinical focus on Pancreatic and Colorectal Cancers.

• Yale School of Medicine (MD 1978, Residency 1982, Fellowship 1985)

Research Pillars: Pioneering therapeutic clinical trials for GI cancers including gastroesophageal, pancreatic, and colorectal cancers, with emphasis on novel therapeutics and translational research. Currently leads investigator-initiated and pharmaceutical trials at Smilow Cancer Center.

Publication Trends (2023-2025): Focused on precision oncology for GI cancers through phase I-III clinical trials, biomarker development, and combination therapies including PARP inhibitors, immune checkpoint combinations, and targeted delivery systems like hepatic arterial infusion.

• Scientific Recognition:
  • Yale Medicine Distinguished Clinical Career Award (2020)
  • American Society of Clinical Oncology Fellow (2021)
  • Castle Connolly Top Doctors (2016-2021)
  • Exceptional Women in Medicine (2019)

Clinical Leadership: Served as Program Director for Hematology-Medical Oncology Fellowship Program (20+ years), actively shapes ASCO educational initiatives, and directs Smilow Cancer Center's GI Malignancies Trials Portfolio. Key collaborations include Yale Cancer Center and National Cancer Institute trials.